These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18602595)

  • 1. Shock therapy. How donut magnets can suspend inappropriate ICD shocks.
    Frascone R; Salzman J; Griffith K; Dunbar D
    JEMS; 2008 Jul; 33(7):104-7. PubMed ID: 18602595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a clinical magnet over implantable cardioverter defibrillators: is it safe and useful?
    Porres JM; Laviñeta E; Reviejo C; Brugada J
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1641-4; dicussion 1645. PubMed ID: 19067820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks.
    Tzeis S; Andrikopoulos G; Kolb C; Vardas PE
    Europace; 2008 Nov; 10(11):1256-65. PubMed ID: 18708639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Magnetic attraction" in the pediatric emergency department: the case of a malfunctioning implantable cardioverter-defibrillator.
    Ladouceur VB; Khairy P; Béland MJ; Bhanji F
    Pediatr Emerg Care; 2012 Jun; 28(6):562-5. PubMed ID: 22668661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of neodymium magnets with cardiac pacemakers and implantable cardioverter-defibrillators: an in vitro study.
    Ryf S; Wolber T; Duru F; Luechinger R
    Technol Health Care; 2008; 16(1):13-8. PubMed ID: 18334784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillators and their role in heart failure progression.
    Cevik C; Perez-Verdia A; Nugent K
    Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate implantable cardioverter-defibrillator magnet-mode switch induced by a laptop computer.
    Tiikkaja M; Aro A; Alanko T; Lindholm H; Hietanen M
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e177-8. PubMed ID: 22353166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance and survival of transvenous defibrillation leads: need for a European data registry.
    Goette A; Cantu F; van Erven L; Geelen P; Halimi F; Merino JL; Morgan JM;
    Europace; 2009 Jan; 11(1):31-4. PubMed ID: 19004838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biventricular implantable cardioverter defibrillator right ventricle pace-sense ring electrode failure: lead switch fix.
    Venkataraman G; Moore H; Karasik P; Singh S; Fletcher R
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):899-903. PubMed ID: 18684289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitation of programmed alerts to predict ICD lead failures.
    Vlay SC
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):554-5. PubMed ID: 19335870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial.
    Russo AM; Day JD; Stolen K; Mullin CM; Doraiswamy V; Lerew DL; Olshansky B
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):973-8. PubMed ID: 19470037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.